Medeon Biodesign Overview

  • Founded
  • 2012

Founded
  • Status
  • Public

  • Stock Symbol
  • 6499

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $1.95

  • (As of Friday Closing)

Medeon Biodesign General Information

Description

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its segment includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from USA.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
ROCO
Primary Office
  • 116, HouGang Street
  • 7th Floor
  • Taipei, 111-70
  • Taiwan
+886 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medeon Biodesign Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.95 $1.94 $1.75 - $3.04 $171M 87.6M 311K -$0.17

Medeon Biodesign Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 101,847 150,531 89,346 92,446
Revenue 8,477 2,468 4,181 14,684
EBITDA (13,162) (16,461) (9,039) (6,140)
Net Income (14,516) 74,368 (6,548) (8,478)
Total Assets 148,860 157,627 118,823 84,037
Total Debt 6,460 1,092 17,666 3,951
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medeon Biodesign Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medeon Biodesign‘s full profile, request access.

Request a free trial

Medeon Biodesign Patents

Medeon Biodesign Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017311506-A1 Suture delivery device for suturing tissue Active 11-Aug-2016 00000000000
JP-7007363-B2 Suture delivery device for suturing tissue Active 11-Aug-2016 00000000000
EP-3496627-A1 Suture delivery device for suturing tissue Pending 11-Aug-2016 00000000000
EP-3496627-A4 Suture delivery device for suturing tissue Pending 11-Aug-2016 00000000000
JP-2019524329-A Suture delivery device for suturing tissue Active 11-Aug-2016 A61B17/0482
To view Medeon Biodesign’s complete patent history, request access »

Medeon Biodesign Executive Team (2)

Name Title Board Seat Contact Info
Yue-Teh Jang Ph.D Founder, Chairman, President & Chief Executive Officer
Shuling Cheng Ph.D Chief Strategy Officer
To view Medeon Biodesign’s complete executive team members history, request access »

Medeon Biodesign Board Members (1)

Name Representing Role Since
Yue-Teh Jang Ph.D Medeon Biodesign Founder, Chairman, President & Chief Executive Officer 000 0000
To view Medeon Biodesign’s complete board members history, request access »

Medeon Biodesign Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (0000 08-Jul-2019 000000000 Clinics/Outpatient Services 000-000 0
0000000 00000 31-May-2019 00000 0000 Therapeutic Devices
Panther Orthopedics 28-Mar-2018 Corporate Therapeutic Devices 000-000 0
To view Medeon Biodesign’s complete investments history, request access »